[1]Gately MK.IL-12:Potential clinical applications in the treatment of chronic viral hepatitis[J].Viral Hepatitis, 1997, 4 (suppl 1) ∶33.
|
[2] 病毒性肝炎防治方案 (试行) [J].中华传染病杂志, 1995, 13∶241.
|
[3] 陆志檬, 杨守纯.血清病毒标志物[M].见:骆抗先编著, 乙型肝炎基础与临床.北京:人民卫生出版社.1997.306.
|
[4]Rossol S, Marrnos G, Carucci P, et al.IL-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B [J].J Clin Invest, 1997, 99∶3025.
|
[5]Rai R, Ananin Z, Boitnoti T, et al.Hepatic expression of IL-12 alters outcome in HBV-infected patients[J].Gastroenterology, 1998, 114 (suppl 1) ∶A1325.
|
[1] | Junting SAI, Xiuhui LI. Research advances in traditional Chinese medicine syndromes of fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(10): 1929-1932. doi: 10.12449/JCH241001 |
[2] | Chong CHEN, Ying LYU, Xilei CHEN, Chenghai LIU, Ping LIU, Yongping MU. Effect of endoscopic ligation combined with traditional Chinese medicine syndrome differentiation-based treatment in the secondary prevention of esophageal variceal bleeding in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(5): 1075-1080. doi: 10.3969/j.issn.1001-5256.2022.05.019 |
[3] | Jiang DENG, Zhiyi HAN, Cailan XIAO, Yating SUN, Yajun JI, Li AO, Yonghong ZHANG, Xiaolan LU. Prevalence rate of non-obese fatty liver disease and related influencing factors[J]. Journal of Clinical Hepatology, 2021, 37(11): 2600-2604. doi: 10.3969/j.issn.1001-5256.2021.11.022 |
[4] | Chen KeDi, Yang DaoFeng, Chen Guang. Clinical features and diagnosis and treatment of acute fatty liver of pregnancy: a report of 12 cases[J]. Journal of Clinical Hepatology, 2018, 34(3): 558-561. doi: 10.3969/j.issn.1001-5256.2018.03.022 |
[5] | Huang YingTing, Dai Biao. Association between fatty liver disease and lacunar infarction[J]. Journal of Clinical Hepatology, 2018, 34(12): 2619-2623. doi: 10.3969/j.issn.1001-5256.2018.12.022 |
[6] | Li XiuChi, Ruan GaiQing, LYU JiaEn, Sun MoQian, Wang MingMing. A preliminary investigation and feature analysis of non-alcoholic fatty liver and nonalcoholic steatohepatitis in employees in an IT company[J]. Journal of Clinical Hepatology, 2017, 33(7): 1324-1327. doi: 10.3969/j.issn.1001-5256.2017.07.024 |
[7] | Meng YuLin, Zhang HaiYan, Song BaoGuo, Zhou HuiLan, Jin XiuPing, Shi GuoHui. An investigation of the prevalence rate of fatty liver disease among people undergoing physical examination in Tangshan, China[J]. Journal of Clinical Hepatology, 2017, 33(12): 2376-2380. doi: 10.3969/j.issn.1001-5256.2017.12.024 |
[8] | He Jia, Li Wei, Li Kuan, Ning HuiBin, Liu JunPing, Mao ZhongShan, Shang Jia. Clinical features of chronic HBV/HCV infection complicated by mild hepatic steatosis[J]. Journal of Clinical Hepatology, 2016, 32(9): 1717-1720. doi: 10.3969/j.issn.1001-5256.2016.09.016 |
[9] | Li JingYing, Li XiuHui, Zhang Yin, Gou ChunYan, Li Li. Syndrome differentiation-based treatment of primary liver cancer developed by Professor Qian Ying: an analysis of experience[J]. Journal of Clinical Hepatology, 2016, 32(7): 1342-1344. doi: 10.3969/j.issn.1001-5256.2016.07.026 |
[10] | Zhang Yu, Cheng Jun. Hepatitis C virus related fatty liver[J]. Journal of Clinical Hepatology, 2015, 31(7): 1034-1037. doi: 10.3969/j.issn.1001-5256.2015.07.009 |
[11] | Pang XueQin, Chen WeiChang, Feng Huang, Tian WenYan. Risk factors for non- alcoholic fatty liver disease: a multivariate analysis[J]. Journal of Clinical Hepatology, 2014, 30(9): 903-905. doi: 10.3969/j.issn.1001-5256.2014.09.016 |
[12] | Huang ZhiPeng, Su ZhiJun, Jiang JianJia, Sun BingQing, Lin ZhenZhong, Ceng ZhiXiong. Correlation of severity of non-alcoholic fatty liver disease with visceral adipose tissue area, body mass index, and waist circumference[J]. Journal of Clinical Hepatology, 2013, 29(6): 445-448. |
[13] | Li Lei, Ding HuiGuo. Clinical features of cirrhosis due to nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1032-1035. |
[14] | Xiang GuoQing, Meng XiaoDan, Wang BingYuan. Prevalence of fatty liver among people with different occupation in Shenyang[J]. Journal of Clinical Hepatology, 2010, 26(3): 283-285. |
[15] | Qin YongJun, Sun JieSheng, Wang BingYuan, Liu PengLiang, Sun FuRong, Liu CuiXiang, Xie DaWei. The differences of the blood routine indexes in patients with fatty liver and non-fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(2): 163-166. |
[16] | Feng XiaoXia, Wang Lei, Xing LianJun, Liang HaiLin, Nie YuanXia. The function of dendritic cell in chronic hepatitis B patients with deficiency of kidney based on traditional chinese medicine syndrome differentiation intervention[J]. Journal of Clinical Hepatology, 2010, 26(6): 638-640. |
[18] | Chen MingWei, Yang MingGong, Wang YouMin, Wang ZhangJiang, Pan TianRong, Hu HongLin, Sun HaiYan. Risk factors analysis on nonalcoholic steatohepatitis in patients with type 2 diabetes[J]. Journal of Clinical Hepatology, 2004, 20(1): 44-45. |
[19] | Ding YanHua, He ShuMei, Wang XiaoWei, Xu MaoFeng, Niu JunQi. The clinical feature of 198 patients with fatty liver[J]. Journal of Clinical Hepatology, 2004, 20(5): 287-288. |